what is the real low down on uterine fibroid embolization? Is it some new con which is out there to make mone

3 Comments

1. Endo says:

   September 25, 2009 at 10:15 am

   Uterine fibroid embolization (also known as uterine artery embolization) represents a fundamentally new approach to the treatment of fibroids. Embolization is a minimally invasive means of blocking the arteries that supply blood to the fibroids. It is a procedure that uses angiographic techniques (similar to those used in heart catheterization) to place a catheter into the uterine arteries. Small particles are injected into the arteries, which results in the blockage of the arteries feeding the fibroids. This technique is essentially the same as that used to control bleeding that occurs after birth or pelvic fracture, or bleeding caused by malignant tumors.

   As of this time, approximately 2000 to 3000 patients have had this procedure world-wide. Initial results suggest that symptoms will be improve in 90% of patients with the large majority of patients markedly improved. Most patients have rated this procedure as very tolerable. The expected average reduction in the volume of the fibroids is 50% in three months, with reduction in the overall uterine volume of about 35%. The long-term outcome is not known, in that the arteries could reopen or collateral vessels could be recruited which might allow regrowth of the fibroids. As of yet this has not been reported in the published series but only short term follow-up is available. Therefore, it is not yet known if the fibroids can regrow.

   The procedure was first used in fibroid patients in France as a means of decreasing the blood loss that occurs during myomectomy. It was discovered that after the embolization, while awaiting surgery, many patient’s symptoms went away and surgery was no longer needed. The blockage of the blood supply caused degeneration of the fibroids and this resulted in resolution of their symptoms. This has led to the use of this technique as a stand-alone treatment for symptomatic fibroids.

   Most patients will experience several hours of moderate to severe pain after the procedure. There may also be nausea, and possibly fever. The pain and nausea is controlled with intravenous medications, usually with a pump that allows self-administration of the medications. After an initial period of bed rest for six to eight hours, those patients with mild to moderate symptoms may be discharged. Most patients are hospitalized overnight. Most symptoms are substantially improved by the next morning allowing discharge from the hospital.

   After discharge, most patients will have periodic moderate to severe cramping over several days. Pain medications are prescribed to control these symptoms. These cramping episodes usually diminish over several days. Most patients will feel tired and may have a fever or nausea periodically. All these symptoms usually resolve over several days, but may last longer. Most women can anticipate returning to work 7 to 14 days after the procedure.

   Complications are anticipated in less than 3% of patients. Serious possible complications include injury to the uterus from decreased blood supply or infection. Fortunately, this is quite rare and hysterectomy to treat either of these complications occurs in less than 1% of patients. Injuries to other pelvic organs is possible but has not yet occurred and the chance of other significant complications is less than 1%.

   Long-term complications are not expected, although several questions about potential side effects remain. X-rays are used to guide the procedure and this raises a concern about potential long-term effects. In a study measuring the X-ray exposure during uterine embolization, the exposure was found to be below the level that would be expected to cause any health effect to the patient herself or to future children.

   It is also uncertain what effect blocking the uterine arteries will have on the ability to become pregnant or to carry a pregnancy to term. The large majority of the patients that had this procedure are finished with childbearing and so few women have tried to become pregnant after this procedure. Thus far, at least a dozen patients have become pregnant after this procedure worldwide. This includes a normal cesarean twin delivery and several normal single vaginal deliveries in France. There has been one reported miscarriage and other patients are pregnant at this time. It is also known that patients who have had this procedure for other reasons, such as bleeding after childbirth, have successfully carried pregnancies. However, most patients that have been treated for fibroids thus far are not interested in having a baby and have not sought to become pregnant. Therefore, without further study, we will not know what percentage of patients that wish to become pregnant will be able to do so. As the outcome of pregnancy following UAE is not know, we cannot recommend the procedure for women who plan to have children.

   Another unresolved question is the effect, if any, of this procedure on the menstrual cycle. The overwhelming majority of women who have had embolization of fibroids have had decreased bleeding with normal menstrual cycles. There have been a few women (most of whom are near the age when menopause would be expected) who have lost their menstrual periods after uterine embolization. It is uncertain whether these cases are a result of decreased ovarian function from the procedure. This question will require further study. Based on this limited information, it appears that this procedure may result in loss of menstrual cycles (premature menopause) in a very small number of patients.
2. starrynight1 says:

   September 25, 2009 at 10:15 am

   I don’t know if it’s the same thing but I had an Endometrial Ablation where they go in and cauterize the uterus. I was having a lot of pain and heavy bleeding and since the operation last December I have felt wonderful. It’s the best thing I’ve ever done.